Dietary Supplements Used for Weight Loss- Pharmacist

  Price  

  Credits  1.5

This product is currently out of stock and unavailable.


Format
Two-thirds of adults in the U.S. are either overweight or obese. Since the late 1970s, the prevalence of obesity among adults has nearly doubled to 34%. Almost 1 of every 5 children is now overweight. The implications of this epidemic are serious; obese people are at increased risk for heart disease, high blood pressure, stroke, diabetes, arthritis-related disabilities, respiratory problems, and some cancers. Consumer spending on dietary supplements for weight loss exceeds $1 billion per year and we are inundated with advertising for these products, which claim to produce weight loss quickly and easily. Unfortunately, there is little or no clinical evidence to support such claims and consumers are largely unaware of this void. About half of all dietary supplement users mistakenly believe that the FDA approves weight loss supplements, verifying both efficacy and safety. One-third believe that these products are safer than OTC or prescription drugs (e.g., orlistat [alliTM, Xenical®], sibutramine [Meridia®]) which are actually subject to much stricter regulations. This issue will update you on the regulation of weight loss supplements and give you a brief review of the products widely used for weight loss, focusing on evidence for benefits and risks. Useful tables summarize the adverse effects and drug interactions linked with these products for “at a glance” review.

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharm/Nurse Drug Therapy

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
  • Universal Activity Number:
    Pharmacist : 428-0000-08-009-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.